NEWLAND PHARMACEUTICAL CO., LTD

E3F57
China Mainland
Company Profile
  • Year Established: 2005
  • Total Assets(USD): 25,000,000 to 29,999,999
  • Total Number of Staff: more than 500
  • Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Small Orders Accepted,Reputation
  • Business Type: Manufacturer
  • Annual Turnover(USD) : 45,000,000 to 49,999,999
  • Main Sales Markets : Asia,Middle East

Henan Newland Pharmaceutical Co., Ltd. was founded in 2005. The registered capital reaches RMB 99,000,000 and the total assets amount to RMB 300,000,000. The company is mainly engaged in research, production and sales of pharmaceutical intermediates and fine chemicals. The leading products, D-(-)-P-Hydroxyphenylglycine and D-(-)-P-Hydroxyphenylglycine Dane Salt, are certificated as Hi-tech products by the Science and Technology Bureau of Henan Province. Both the two products are listed by the Government of Henan Province on the first and second group of important projects of hi-tech industrialization. In addition, our company is the earliest manufacturer to research and produce D-(-)-P-hydroxyphenylglycine and its derivatives, and the quality parallels the international advanced level. The company is identified as National Hi-tech Enterprise, Key Enterprise in Ministry of Commerce, and Key Hi-tech Products Exporter of Henan Province, Innovative Pilot Enterprise of Henan Province,

Year Established: 2005

Total Assets(USD): 25,000,000 to 29,999,999

Total Number of Staff: more than 500

Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Small Orders Accepted,Reputation

Business Type: Manufacturer

Annual Turnover(USD) : 45,000,000 to 49,999,999

Main Sales Markets : Asia,Middle East

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by